CurrentCardio coverage · page 2 of 17
JACC
Latest from JACC
J Am Coll Cardiol
Long-Term Exposure to PM2.5 Constituents and Coronary Heart Disease Risk in China
Cohort studyCoronary & ACS
J Am Coll Cardiol
Myocardial Scar Assessment Using Artificial Intelligence-Powered Contrast-Free MRI: A Prospective Multicenter Study of Virtual Native Enhancement
Diagnostic or prognostic studyCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry
Cohort studyHeart failure
J Am Coll Cardiol
Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
Associations Between PM2.5 Components and Cardiovascular Diseases: A Cohort Study of 0.5 Million Chinese Adults
Cohort studyCardio-oncology & other
J Am Coll Cardiol
Contemporary Outcomes of the Ross Procedure in Adults: Implications for Current Clinical Practice
Cohort studyValvular & structural
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis
Secondary analysisValvular & structural
J Am Coll Cardiol
Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE Study
Cross-sectional studyValvular & structural
J Am Coll Cardiol
Combined LDL-C, Lp(a), and hsCRP Assessment Predicts ASCVD in the Multiethnic HELIUS Cohort
Cohort studyPrevention & lipids
J Am Coll Cardiol
Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial
Secondary analysisCoronary & ACS
J Am Coll Cardiol
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Guideline or statementCardiometabolic & kidney
J Am Coll Cardiol
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Guideline or statementPrevention & lipids
J Am Coll Cardiol
Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis
Secondary analysisCardiometabolic & kidney
J Am Coll Cardiol
J Am Coll Cardiol
Estimating the Effects of MTEER in U.S. Practice: A Transportability Analysis of the COAPT Trial
Randomised controlled trialValvular & structural
J Am Coll Cardiol
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses
Secondary analysisCardiometabolic & kidney
J Am Coll Cardiol
J Am Coll Cardiol
Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial
Randomised controlled trialHeart failure
J Am Coll Cardiol
Implications of Modest Reductions in ABI Measurements for Risk of Major Adverse Limb Events Among 223,350 Veterans
Cohort studyAortic & peripheral
J Am Coll Cardiol
Contemporary Management of Acute Heart Failure: From Emergency Presentation to Long-Term Remission
Guideline or statementHeart failure
J Am Coll Cardiol
Anti-Inflammatory Effects of Oral NLRP3 Inhibition With Ruvonoflast Among Individuals at Elevated Cardiovascular Risk
Randomised controlled trialPrevention & lipids
J Am Coll Cardiol
Resistance Training, Aerobic Activity, Television Viewing, and Risk of Major Cardiovascular Events in U.S. Women
Cohort studyPrevention & lipids
J Am Coll Cardiol
Chronic PM2.5 Exposure Is Associated With Invasively Assessed Coronary Endothelial Dysfunction
Cohort studyCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
Accelerated Diagnostic Pathways for Suspected Acute Coronary Syndrome in Practice: A Randomized Trial of 0/1-Hour vs 0/3-Hour Troponin Testing
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF Trial
Randomised controlled trialHeart failure
J Am Coll Cardiol
J Am Coll Cardiol
Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK Trial
Randomised controlled trialAortic & peripheral
J Am Coll Cardiol
Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease
Secondary analysisArrhythmias & EP
J Am Coll Cardiol
ECG Signatures and Long-Term Ischemic Stroke Risk: A Deep Learning Analysis of 200,000 Patients
Diagnostic or prognostic studyArrhythmias & EP
J Am Coll Cardiol
Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia: A Population-Based Cohort Study
Meta-analysisPrevention & lipids
J Am Coll Cardiol
J Am Coll Cardiol